The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Diagnosed Incident Population of Fibromyalgia, Gender-specific Diagnosed Incidence of Fibromyalgia, Type-specific Diagnosed Incidence of Fibromyalgia, Age-specific Diagnosed Incidence of Fibromyalgia, Diagnosed Incident Population based on Primary Site of Fibromyalgia, and Diagnosed Incident Population based on Histologic Classification of Fibromyalgia Tumour in the global market covering North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa from 2024 to 2035.